Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 68475-010

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 68475-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8b0eafef 98ef 4407 A98f 4f1dd84d1e56 01)

Chemical structure diagram of sevelamer carbonate showing the polymer backbone with ammonium and bicarbonate groups, illustrating its composition relevant to its function as a phosphate binder.*

FDA Label Image

Image (8b0eafef 98ef 4407 A98f 4f1dd84d1e56 02)

A forest plot graph showing subgroup analyses comparing Sevelamer carbonate versus placebo. The chart includes confidence intervals and mean differences for various groups such as screening BSA, baseline serum phosphorus, age, and dialysis status, with a scale indicating which treatment is favored.*

FDA Label Image

Image (8b0eafef 98ef 4407 A98f 4f1dd84d1e56 03)

A line graph depicting the percentage of patients with a 2-fold reduction or more against the reduction in serum phosphorus (mg/dL). It compares Sevelamer hydrochloride with an active control, showing patient response over a range of serum phosphorus reductions from -4 to 8 mg/dL.*

FDA Label Image

Image (8b0eafef 98ef 4407 A98f 4f1dd84d1e56 04)

A line graph depicting phosphorus change from baseline over a 52-week study period. Two treatment groups, Sevelamer Hydrochloride and Active-Control, are plotted with phosphorus change on the vertical axis and study weeks on the horizontal axis. The graph shows trends of phosphorus reduction over time for both groups.*

FDA Label Image

Bottle-270-pdp (8b0eafef 98ef 4407 A98f 4f1dd84d1e56 05)

Label for Sevelamer Carbonate Tablets 800 mg, film-coated, containing 270 tablets for oral use. The label includes the NDC 68475-010-02 and lists active and inactive ingredients, storage instructions, and manufacturer details for Navinta LLC, Ewing, NJ. The label also features a barcode and a reserved unvarnished area for additional coding.*

FDA Label Image

Bottle-30-pdp (8b0eafef 98ef 4407 A98f 4f1dd84d1e56 06)

Label for Sevelamer Carbonate Tablets 800 mg film-coated tablets by Navinta LLC. The label includes the active ingredient, dosage strength, a barcode, manufacturer details, storage instructions, and a statement about dispensing in a tight container. It specifies a 30 tablet count and indicates Rx only. There is an unvarnished area for additional labeling information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.